Lex IP Meister, PLLC
Gremlin-1 antibody
The present invention relates to a Gremlin-1 antibody that inhibits Gremlin-1 in a manner independent of bone morphogenetic protein (BMP) or vascular endothelial growth factor receptor-2 (VEGFR-2), thus providing the effect of treating cancer. The antibody of the present invention inhibits cell migration, cell invasion and cell proliferation which are dependent on Gremlin-1, and therefore, can be effectively used in treating cancer or immune disease.
SNU R&DB FOUNDATION
A A A A C C A A A A C A C A C C A A C C A C A A A C A A
A61P A61P A61P A61P C07K C07K A61P A61P A61P A61P C07K A61P C07K A61P C07K C07K A61P A61P C07K C07K A61P C07K A61P A61P A61P C07K A61P A61P
inventional inventional inventional inventional additional additional inventional inventional inventional inventional additional inventional additional inventional additional inventional inventional inventional inventional additional inventional additional inventional inventional inventional inventional inventional inventional
Soo Min Hyun Kee Junho Min Soo
Yoon Kim Chung Kim